Literature DB >> 9104687

Relationship between napping and melatonin in the blind.

S W Lockley1, D J Skene, H Tabandeh, A C Bird, R Defrance, J Arendt.   

Abstract

Daytime sleepiness is a common complaint in blind subjects. Abnormally timed melatonin has been invoked as a possible cause of both daytime sleepiness and nighttime awakening. In free-running blind individuals, there is an opportunity to assess the relationship between endogenous melatonin rhythms and subjective sleepiness and naps. The aim of this study was to characterize melatonin rhythms and simultaneously to evaluate subjective napping. A total of 15 subjects with no conscious light perception (NPL) were studied for 1 month. Prior to the study, sleep disorders were assessed using the Pittsburgh Sleep Quality Index. Cosinor and regression analysis revealed that 9 of the 15 NPL subjects had free-running 6-sulphatoxymelatonin (aMT6s) rhythms (period [tau] range = 24.34 to 24.79 h), 3 were entrained with an abnormal phase, and 3 were normally entrained. Most of the subjects (13 of 15) had daytime naps; the 2 individuals who did not made conscious efforts not to do so. Subjects with abnormal aMT6s rhythms had more naps of a longer duration than did those with normal rhythms. Free-running nap rhythms occurred only in subjects with free-running aMT6s rhythms. The 2 abnormally entrained subjects who napped did so at times that coincided with high levels of aMT6s (mean aMT6s acrophase [phi] +/- SD = 14.30 +/- 1.08 h, 20.30 +/- 0.62 h; mean nap time +/- SD = 14.01 +/- 3.60 h, 18.23 +/- 3.20 h, respectively). Regardless of aMT6s rhythm abnormality, significantly more naps occurred with a 4-h period before and after the estimated aMT6s acrophase. In 4 free-running subjects, aMT6s acrophase (phi) passed through an entire 24-h period. When aMT6s was in a normal phase position (24:00 to 06:00 h), night-sleep duration tended to increase with a significant reduction in the number and duration of naps. Sleep onset and offset times tended to advance and delay as the aMT6s rhythms advanced and delayed. Our results show a striking relationship between the timing of daytime production of melatonin and the timing of daytime naps. This suggests that abnormally timed endogenous melatonin may induce sleepiness in blind subjects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9104687     DOI: 10.1177/074873049701200104

Source DB:  PubMed          Journal:  J Biol Rhythms        ISSN: 0748-7304            Impact factor:   3.182


  23 in total

1.  Late evening brain activation patterns and their relation to the internal biological time, melatonin, and homeostatic sleep debt.

Authors:  Tali Gorfine; Nava Zisapel
Journal:  Hum Brain Mapp       Date:  2009-02       Impact factor: 5.038

2.  Are We Ready to Assess Circadian Phase at Home?

Authors:  Shadab A Rahman
Journal:  Sleep       Date:  2015-06-01       Impact factor: 5.849

3.  Effect of tart cherry juice (Prunus cerasus) on melatonin levels and enhanced sleep quality.

Authors:  Glyn Howatson; Phillip G Bell; Jamie Tallent; Benita Middleton; Malachy P McHugh; Jason Ellis
Journal:  Eur J Nutr       Date:  2011-10-30       Impact factor: 5.614

Review 4.  Tasimelteon: first global approval.

Authors:  Sohita Dhillon; Madeleine Clarke
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

Review 5.  Circadian rhythm sleep disorders: pathophysiology and potential approaches to management.

Authors:  N Zisapel
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

6.  Free-running circadian rhythms of muscle strength, reaction time, and body temperature in totally blind people.

Authors:  Camila Fabiana Rossi Squarcini; Maria Laura Nogueira Pires; Cleide Lopes; Ana Amélia Benedito-Silva; Andrea Maculano Esteves; Germaine Cornelissen-Guillaume; Carolina Matarazzo; Danilo Garcia; Maria Stella Peccin da Silva; Sergio Tufik; Marco Túlio de Mello
Journal:  Eur J Appl Physiol       Date:  2012-05-23       Impact factor: 3.078

7.  Sleep and circadian rhythms in hospitalized patients with decompensated cirrhosis: effect of light therapy.

Authors:  M De Rui; B Middleton; A Sticca; A Gatta; P Amodio; D J Skene; S Montagnese
Journal:  Neurochem Res       Date:  2014-08-19       Impact factor: 3.996

8.  Melatonin advances the circadian timing of EEG sleep and directly facilitates sleep without altering its duration in extended sleep opportunities in humans.

Authors:  Shantha M W Rajaratnam; Benita Middleton; Barbara M Stone; Josephine Arendt; Derk-Jan Dijk
Journal:  J Physiol       Date:  2004-09-30       Impact factor: 5.182

Review 9.  Role of the melatonin system in the control of sleep: therapeutic implications.

Authors:  Seithikurippu R Pandi-Perumal; Venkatramanujan Srinivasan; D Warren Spence; Daniel P Cardinali
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

10.  Sleep and circadian abnormalities in patients with cirrhosis: features of delayed sleep phase syndrome?

Authors:  Sara Montagnese; Benita Middleton; Ali R Mani; Debra J Skene; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2009-09       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.